Andreas Hüttmann
Impact in
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
- Hematology top 2%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 38
- Oncology 15
- CAR-T cell therapy research 8
- Co-authors
- Ulrich Dührsen (39 shared papers)Jan Dürig (12 shared papers)Andy Boyd (3 shared papers)Dieter Hoelzer (5 shared papers)Albrecht Reichle (5 shared papers)Nicola Gökbuget (4 shared papers)K. Renzing‐Köhler (1 shared paper)Andreas Viardot (8 shared papers)
- Journals
- Blood (21 papers)Leukemia (4 papers)British Journal of Haematology (3 papers)PLoS ONE (2 papers)Cancers (2 papers)
- Partner nations
- GermanyNetherlandsSwitzerland
In The Last Decade
Andreas Hüttmann
64 papers receiving 1.7k citations
Andreas Hüttmann's Hit Papers
Peers
Comparison fields: 5 of 82
- Genetics 419
- Hematology 411
- Pathology and Forensic Medicine 530
- Oncology 454
- Public Health, Environmental and Occupational Health 395
Countries citing papers authored by Andreas Hüttmann
This map shows the geographic impact of Andreas Hüttmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Hüttmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Hüttmann more than expected).
Fields of papers citing papers by Andreas Hüttmann
This network shows the impact of papers produced by Andreas Hüttmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Hüttmann. The network helps show where Andreas Hüttmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Andreas Hüttmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation Hit paper breakdown → | 2012 | 325 |
| 2 | 2002 | 173 | |
| 3 | 2011 | 128 | |
| 4 | 2022 | 82 | |
| 5 | 2018 | 79 | |
| 6 | 1999 | 72 | |
| 7 | 2003 | 70 | |
| 8 | 2006 | 70 | |
| 9 | 2019 | 65 | |
| 10 | 2011 | 52 | |
| 11 | 2001 | 48 | |
| 12 | 2006 | 43 | |
| 13 | 2022 | 43 | |
| 14 | 2012 | 41 | |
| 15 | 2005 | 39 | |
| 16 | 2017 | 35 | |
| 17 | 2009 | 32 | |
| 18 | 2013 | 29 | |
| 19 | 1998 | 27 | |
| 20 | 2020 | 27 |
About Andreas Hüttmann
Andreas Hüttmann is a scholar working on Pathology and Forensic Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Genetics and Immunology, having authored 66 papers that have together received 1.8k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (38 papers), Chronic Lymphocytic Leukemia Research (12 papers), Medical Imaging Techniques and Applications (9 papers), CAR-T cell therapy research (8 papers), Lung Cancer Treatments and Mutations (7 papers), Acute Lymphoblastic Leukemia research (6 papers), Radiomics and Machine Learning in Medical Imaging (5 papers) and Complement system in diseases (4 papers). The work is most often cited by research in Genetics (419 citations), Hematology (411 citations), Pathology and Forensic Medicine (530 citations), Oncology (454 citations) and Public Health, Environmental and Occupational Health (395 citations). Andreas Hüttmann has collaborated with scholars based in Germany, Netherlands and Switzerland. Frequent co-authors include Ulrich Dührsen, Jan Dürig, Andy Boyd, Dieter Hoelzer, Albrecht Reichle, Nicola Gökbuget, K. Renzing‐Köhler, Andreas Viardot, U Schmücker and Joachim Beck. Their work appears in journals such as Blood, Leukemia, British Journal of Haematology, PLoS ONE and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.